Ergoteles’s Instil Bio TIL Stock Holding History

Ergoteles’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,969	Closed	-$26K	–	1523
2023 Q1	$26K	Buy	1,969 +94	+5%	+$1.39K	﹤0.01%	1150
2022 Q4	$23.6K	Buy	+1,875	New	+$92.7K	﹤0.01%	1341
2021 Q4	–	Sell	-3,996	Closed	-$1.43M	–	1592
2021 Q3	$1.43M	Buy	+3,996	New	+$1.49M	0.05%	313

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's TIL Position: Q2 2023 in Review

Ergoteles sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 1,969 shares — an estimated $26K sold.

Ergoteles first reported a position in TIL in Q3 2021 and held it in 3 quarters. The position peaked at $1.43M in Q3 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

Ergoteles reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 1,969 Instil Bio shares in Q2 2023, an estimated $26K.
Ergoteles first reported a position in Instil Bio in Q3 2021 and held it in 3 quarters.
Ergoteles's Instil Bio position peaked at $1.43M in Q3 2021.
62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.